Gastroesophageal Reflux Disease News and Research

RSS

Gastroesophageal reflux disease (GERD) is a more serious form of gastroesophageal reflux (GER), which is common. GER occurs when the lower esophageal sphincter (LES) opens spontaneously, for varying periods of time, or does not close properly and stomach contents rise up into the esophagus. GER is also called acid reflux or acid regurgitation, because digestive juices—called acids—rise up with the food. The esophagus is the tube that carries food from the mouth to the stomach. The LES is a ring of muscle at the bottom of the esophagus that acts like a valve between the esophagus and stomach.

Study links acid-reducing drugs to increased risk of migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

24 Apr 2024

Over 80% of semaglutide users achieve significant weight loss after 12 months, study finds

...

5 Feb 2024

Comparing perioperative differences: Sleeve gastrectomy vs. Roux-en-Y gastric bypass

Study compares laparoscopic sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) in obese patients, finding both procedures have low, comparable perioperative risks and complications, challenging the criteria for selecting between the two surgeries.

1 Feb 2024

Gastric bypass shows slight edge over sleeve gastrectomy in long-term study

The long-term weight loss effects of sleeve gastrectomy and Roux-en-Y gastric bypass in people with obesity.

25 Jan 2024

Study challenges link between proton pump inhibitors and kidney disease risk

A study in Scientific Reports investigates the association between proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RA) use on chronic kidney disease (CKD) risk.

5 Dec 2023

Can ketogenic diet offer an effective alternative to antiseizure medication in infants with drug-resistant epilepsy?

The effectiveness of ketogenic diets in lowering seizure frequency among newborns.

5 Dec 2023

How does GERD increase the risk of heavy menstrual bleeding?

Study explores the potential causal link between GERD, a common gastrointestinal issue, and the risk of heavy menstrual bleeding (HMB) in women. The analysis suggests a potential causal relationship, although the results were inconclusive, pointing to the complexity of hormonal interactions in both conditions.

27 Aug 2023

EHR-embedded AI tool can identify patients at risk for esophageal and stomach cancer

In the United States and other western countries, a form of esophageal and stomach cancer has risen dramatically over the last five decades. Rates of esophageal adenocarcinoma, or EAC, and gastric cardia adenocarcinoma, or GCA, are both highly fatal.

22 Aug 2023

Long-term use of proton pump inhibitors associated with increased risk of dementia

Researchers determine whether the current and cumulative use of prescription proton pump inhibitors increases the risk of incident dementia.

17 Aug 2023

Dementia risk may increase with long-term use of acid reflux drugs

People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people who do not take these medications, according to new research published in the August 9, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

9 Aug 2023

AGA announces support for the reintroduced Treat and Reduce Obesity Act

The American Gastroenterological Association (AGA) today announced support for the reintroduced Treat and Reduce Obesity Act (TROA), which would expand Medicare coverage to include screening and treatment of obesity from a diverse range of health care providers who specialize in obesity care.

3 Aug 2023

Biomarker found in urine could help diagnose acute tubulointerstitial nephritis

In a study led by Johns Hopkins Medicine, in collaboration with Yale School of Medicine, researchers have identified a biomarker found via a simple urine test that can be used to diagnose acute tubulointerstitial nephritis (AIN), a medical condition that causes inflammation of the kidneys and can lead to acute kidney injury (AKI) — a sudden loss of kidney function.

5 Jul 2023

Research finds fever to be the most common non-respiratory feature of SARS-CoV-2 infection

Fever was found to be the most common non-respiratory feature of infection with SARS-CoV-2, the virus that causes COVID-19, according to research published at the ATS 2023 International Conference.

23 May 2023

Hackensack Meridian JFK University Medical Center launches new Gastroesophageal Reflux and Motility Program

Hackensack Meridian JFK University Medical Center today announced the opening of its new Gastroesophageal Reflux and Motility Program to provide expert diagnosis and treatment of gastroesophageal reflux disease, commonly known as GERD, and other, related motility disorders that affect the muscles in the gastrointestinal tract.

20 Mar 2023

Gut microbiomes and mental health: how do they interact?

A new study published in the journal Frontiers in Medicine reviewed recent literature on the link between gut microbiota, the brain, and neurological disorders.

19 Mar 2023

What is the gastrointestinal impact of Long Covid?

Researchers assessed gastrointestinal outcomes associated with COVID-19.

9 Mar 2023

Is physical activity associated with the risks of hospitalization for common health conditions?

Researchers assessed the relationship between physical activity levels and hospitalization risk.

20 Feb 2023

Ingestible sensor could offer an alternative to invasive procedures used to diagnose motility disorders

Engineers at MIT and Caltech have demonstrated an ingestible sensor whose location can be monitored as it moves through the digestive tract, an advance that could help doctors more easily diagnose gastrointestinal motility disorders such as constipation, gastroesophageal reflux disease, and gastroparesis.

13 Feb 2023

Protein adduction and p53 tumor suppressor inhibition

Researchers assessed the impact of protein adduction on p53 tumor suppressor inhibition.

27 Jan 2023

Study reveals an increase in the prevalence of digestive diseases

Data from a new pan-European study on the burden of digestive diseases, presented today at UEG Week 2022 and published in the United European Gastroenterology Journal, highlights a worrying increase in the prevalence of several digestive diseases since 2000. These include chronic liver diseases, pancreatitis, gastroesophageal reflux disease, gastritis, vascular intestinal disorders and coeliac disease in children. In addition, the incidence and mortality rates for all digestive cancers combined have increased by 26% and 17% respectively in the period 2000-2019.

10 Oct 2022